BBIO
BridgeBio Pharma Inc.
Latest News for BBIO
BridgeBio Pharma received a Hold rating and price target from Citi analyst today. In addition to Citi, BridgeBio Pharma also received a Hold from J......
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Cardiol Therapeutics (CRDL) and BridgeBio Pharma (BB......
The latest announcement is out from BridgeBio Pharma ( ($BBIO) ). On May 7, 2026, BridgeBio Pharma, Inc. filed an automatic shelf registration stat......
BridgeBio Pharma ( ($BBIO) ) just unveiled an announcement. BridgeBio reported first-quarter 2026 revenue of $194.5 million, largely driven by $180......
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Amgen (AMGN) and BridgeBio Pharma (BBIO) with bullis......
Barclays analyst Eliana Merle maintained a Buy rating on BridgeBio Pharma today and set a price target of $157.00. According to TipRanks, Merle is ......
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Qiagen (QGEN) and BridgeBio Pharma (BBIO). Qiagen (QGEN) In a rep......
With markets stabilizing and investors moving back to high-growth names, a handful of companies are standing out for their strong momentum, improvi......
News data is sourced from MarketXLS API and updated regularly.
Showing 8 of 8 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BBIO | $67.73 | -2.0% | 2.42M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |